PFS Soars: AbbVie’s Phase 3 Results Ignite Hope!

Introduction and Recent Performance

Positive news in the biotech world has lifted market sentiment broadly – for example, AbbVie’s recent Phase 3 trial success in Crohn’s disease showed markedly improved remission rates (55% of patients on Skyrizi vs 30% on placebo) (news.abbvie.com). This optimism has spilled over to many stocks, and Provident Financial Services (NYSE: PFS) is no exception. PFS shares have rallied strongly in recent months, with the company’s market capitalization up about 38% year-over-year (stockanalysis.com). At around $23–24 per share, PFS trades near its 52-week high (after bottoming near $17) and still offers a ~4% dividend yield (stockanalysis.com). Below, we dive into PFS’s fundamentals – covering its dividend policy, leverage and funding, valuation, and key risks – to assess whether the stock’s surge is supported by underlying strength.

Limited Window

Six Months of Fry's Investment Report

Special: 80% off — $49 for six months
$49
Normally $499/yr

Get the optical fiber report, robotics trio, AGI briefing, energy analysis, and Insider Exodus — plus weekly updates.

12 new picks/year
Weekly market alerts
90-day money back

Join Now — Lock In $49

Hurry — offer window closing soon.

(function(){
// small, self-contained countdown (shows days left to increase urgency)
var el=document.getElementById(‘fr-urg-‘);
try{
var now=new Date();
// pseudo-expiration: 6 days from now
var exp=new Date(now.getTime() + 6*24*60*60*1000);
var days=Math.ceil((exp-now)/(24*60*60*1000));
el.innerText = ‘Limited time: offer ends in ‘ + days + ‘ day' + (days>1?'s':”) + ‘.';
}catch(e){/*ignore*/}
})();

Dividend Policy, History & Yield

PFS has a well-established quarterly dividend of $0.24 per share, or $0.96 annually, which at the current share price yields roughly 4–4.5% (stockanalysis.com). This dividend has remained unchanged since late 2021, when it was raised modestly from $0.23 – a sign of prudent management during and after the bank’s merger integration. Notably, PFS maintained its dividend through the pandemic and its 2024 acquisition of Lakeland Bancorp, reflecting a commitment to returning cash to shareholders. In fact, the Board declared a $0.24 quarterly dividend again in early 2025 and “plans to continue to maintain a regular quarterly cash dividend” going forward, subject to the bank’s performance and regulatory considerations (www.sec.gov).

Dividend coverage appears comfortable. In 2025, PFS generated $291 million in net income (about $2.35 EPS) while paying roughly $125 million in dividends – a payout ratio around 40–45% (stockanalysis.com). This indicates the dividend is well-covered by earnings and leaves room for retention. During 2024, payout ratios were temporarily elevated (near 87% of net income) due to one-time merger costs, but management anticipated the earnings rebound and kept the dividend steady (www.sec.gov) (www.sec.gov). Given the normalized profits in 2025–2026, PFS’s dividend looks sustainable, though any future raises will likely be measured. It’s worth noting that share buybacks have been minimal recently – PFS repurchased only ~90,000 shares in 2024 (mainly to offset employee stock vesting) (www.sec.gov) – as the company conserved capital after its acquisition. Overall, PFS’s dividend track record and current yield position it as an attractive income play, provided earnings remain on track.

FREE: Discover a Safer, Simpler Way to Start Trading Options

Get the quick-start playbook — plain English, step-by-step trade examples, and the one move pros use to protect their accounts.

United States +1United Kingdom +44Canada +1Australia +61Other

Optional: add your phone number on the next page for VIP alerts

Leverage, Funding & Debt Maturities

Having roughly doubled in size from the Lakeland merger, PFS today operates as a “super-community” bank with ~$25 billion in assets. Balance sheet leverage and capital appear solid. As of Q1 2026, Provident’s Tier 1 leverage ratio is about 10.4% and total risk-based capital ratio ~13.1% (weissratings.com) – comfortably above regulatory minimums. In fact, regulators imposed conditions that PFS maintain a Tier 1 leverage ratio of at least 8.5% for three years post-merger (www.bankingdive.com), and the bank is currently exceeding that by roughly 200 basis points. To bolster capital for the merger, PFS issued $225 million of Tier 2 subordinated notes in May 2024 at a 9.00% fixed rate (due 2034) (www.sec.gov). Together with Lakeland’s assumed debt, this brought total subordinated debentures to about $402 million outstanding (www.sec.gov). While the 9% coupon is hefty (reflecting 2024’s high-rate environment), this debt injection provided capital cushion and regulatory approval for the deal. The subordinated debt is fixed-to-floating, so PFS can likely refinance or call it in the future if rates ease.

On the funding side, PFS relies primarily on deposits but does use wholesale borrowings to support loan growth. The loan-to-deposit ratio stands around 103% (www.sec.gov), indicating loans modestly exceed core deposits. Accordingly, the bank has tapped other funding sources – chiefly the Federal Home Loan Bank. As of year-end 2024, PFS had about $1.9 billion in wholesale borrowings (FHLB advances, lines, and repo agreements) (www.sec.gov) (www.sec.gov). Importantly, a large portion of these are short-term: roughly $1.27 billion (two-thirds of the total) matures within one year (www.sec.gov). This emphasizes some refinancing risk; however, such advances are typically rolled over as needed. Notably, PFS did utilize the Federal Reserve’s Bank Term Funding Program (BTFP) for cheaper liquidity during the 2023 banking turmoil, but it fully repaid the Fed borrowing by late 2024 (www.sec.gov).

Trump

URGENT: Get “Trump\'s Secret Fund” — Learn How to Collect Royalty Checks

Limited report reveals the #1 American oil & gas royalty play that can start paying monthly — with just $50.

Mobile-friendly
Start w/ $50

Yes — Send My Report
Fast download • Instant access • Seats limited

Crucially, core deposits remain PFS’s anchor. The bank’s deposit base is granular and largely retail/business-focused, helping keep funding costs in check – total deposit interest cost was ~2.25% as of Q4 2024 (www.kbra.com), and actually eased to 1.94% in Q1 2026 as high-cost CDs and brokered deposits ran off (www.sec.gov). PFS appears to have navigated the industry’s rate war reasonably well: its deposit beta (pass-through of Fed rate hikes) has been “controlled” thanks to a solid mix of low-cost core deposits (www.kbra.com). Uninsured deposits are also at a moderate level – about 26% of total deposits (excluding fully collateralized municipal accounts) – which is relatively low by industry standards (www.kbra.com). Furthermore, liquidity backstops are ample: management has approximately $7 billion in contingent liquidity (cash, Fed/FHLB lines, etc.), which is over 1.5× the level of uninsured deposits (www.kbra.com). In short, even if depositor sentiment were to sour, PFS has a liquidity buffer to withstand outflows. Overall, leverage and funding metrics suggest PFS is prudently leveraged – regulatory capital is strong, and while the bank does carry more wholesale funding after its growth spurt, it maintains significant liquidity and a loyal deposit base to support that stance.

Earnings Power and Profitability Coverage

Provident’s earnings profile has strengthened materially post-merger. In 2025, the first full year including Lakeland, PFS’s net interest income surged to $600.6 million (from $399 million prior year) (www.sec.gov) (www.sec.gov), driving net income to $291 million – up 152% year-on-year (stockanalysis.com). Even excluding one-time merger expenses, core profitability is robust. The bank’s return on assets (ROA) in late 2024 was about 1.05% on a core basis (www.kbra.com), and management expects ~1.3% ROA going forward as cost synergies and loan growth fully materialize (www.kbra.com) (www.sec.gov). Net interest margin (NIM) has been holding in the mid-3% range – PFS reported a 3.40% NIM in Q1 2026 (www.sec.gov) – and could stabilize or even expand slightly if funding costs continue to decline. In fact, PFS is relatively asset-liability neutral: its balance sheet is positioned so that Fed rate cuts (widely expected after 2024) should not hurt net interest income much (www.kbra.com) (www.kbra.com). Rising loan yields on a growing portfolio are offsetting pressure from higher deposit rates, and as older loans reprice upward, management projected NIM in the 3.35%–3.45% range in 2025 (www.kbra.com) – a target the bank is essentially achieving. Non-interest income is a smaller part of the picture (14% of revenue in 2024) (www.kbra.com), but PFS does generate steady fee income from insurance brokerage and wealth management, which it aims to grow.

From a coverage standpoint, PFS easily covers its obligations. Interest coverage (earnings vs. interest expense) is strong thanks to the healthy margin – net interest income covers total interest expense by over 1.3×, and the bank’s efficiency ratio (expenses as % of revenue) has improved to the low 50s%. Dividend coverage is also solid, as noted: the ~$101 million in cash dividends paid in 2024 and ~$125 million in 2025 were comfortably absorbed by earnings (www.sec.gov) (stockanalysis.com). Even under higher capital requirements, PFS’s internal capital generation (earnings retained after dividends) is raising its tangible equity. Book value per share climbed to $21.97 by Q1 2026 (tangible book ~$16.03) (www.sec.gov), up from the high $15s tangible book a year prior – despite paying dividends – illustrating that earnings are more than covering shareholder distributions and growth investments. Asset quality metrics further bolster the picture: net charge-offs have averaged just 0.20% of loans annually since 2007 (www.kbra.com), and PFS maintains a healthy reserve. The allowance for credit losses stood at 1.04% of total loans and a hefty 268% of non-performing loans at 2024 year-end (www.sec.gov), reflecting conservative provisioning. In short, PFS’s core earnings easily cover its interest costs and dividend, leaving a margin of safety for future growth or tough times.

Valuation and Peer Comparison

After its recent rally, PFS stock is trading at a valuation in line with high-quality regional bank peers. At ~$23.50 per share, PFS’s price-to-earnings ratio is about 10× (trailing EPS ~$2.35) (stockanalysis.com). This is a modest multiple – roughly a 10% earnings yield – consistent with broader regional bank valuations in the single-digits to low-teens P/E. Given PFS’s above-average ROA and double-digit ROE, a P/E around 10 suggests the market views its earnings as relatively low-risk but still assigns a small discount due to the sector’s cautious sentiment. On a book value basis, the stock trades around 1.1× current book and ~1.5× tangible book (www.sec.gov). PFS’s book value per share is $21.97 (with considerable goodwill from the merger), and tangible book is about $16.03 (www.sec.gov). Paying ~1.5× tangible book for a bank with ~16% return on tangible equity (www.sec.gov) and a stable deposit franchise indicates a fair valuation – neither a steep bargain nor overly rich.

For context, many mid-sized banks of similar quality trade near 1.2× tangible book and 9–11× earnings, so PFS’s valuation is within the expected range. The stock’s dividend yield near 4% also provides support (stockanalysis.com), as income-oriented investors find that attractive in a low-growth environment. It’s worth noting that PFS’s valuation has re-rated upward from early 2023 lows (when banking turmoil drove sector P/B multiples well below 1× in some cases), reflecting improved confidence in its outlook. The market appears to be recognizing PFS’s strong fundamentals – high capital, low credit risk, and integration success – by awarding a slight premium to book value. Still, upside from here may depend on delivering further earnings growth or efficiency gains, as the current price already factors in much of the post-merger rebound. Analysts have a consensus price target around $25 (roughly 1.05× forward book), which implies only mid-single-digit upside from the latest price (stockanalysis.com) (stockanalysis.com). In sum, PFS is reasonably valued: investors are paying a fair price for a bank with steady 10%+ annualized returns and a reliable dividend, but the stock is no longer the deep value it might have been at lower levels.

Key Risks and Red Flags

Despite its strengths, PFS faces several risks and potential red flags that warrant monitoring:

Commercial Real Estate Concentration: Provident’s loan portfolio is heavily weighted to commercial real estate (CRE). By year-end 2024, investor CRE loans equated to ~433% of the bank’s capital – well above regulatory guidelines (300% of capital) for concentration risk (www.kbra.com). This exposes PFS to any downturn in the CRE market. A sharp decline in commercial property values or tenant stress (e.g. in office buildings) could lead to higher defaults. Mitigating this, management emphasizes that their CRE book is high quality – they favor low-leverage loans with strong debt coverage and reputable guarantors (www.kbra.com). Indeed, only ~5% of total loans are in office properties (the weakest CRE segment) (www.kbra.com). PFS’s historical credit performance has been excellent (net charge-offs well below peers) (www.kbra.com), suggesting stringent underwriting. Nonetheless, the risk remains that if interest rates stay elevated or a recession hits, even solid CRE borrowers could struggle to refinance. Investors should watch for any rise in “criticized” or classified loans, which ticked up industry-wide over the past year (www.kbra.com). To date, PFS reports that its criticized loan levels remain manageable (www.kbra.com), but CRE exposure will be a key credit risk to monitor in 2024–2025 as many loans mature and reprice.

Reliance on Wholesale Funding: The flip side of PFS’s strong loan growth is its dependence on non-deposit funding. With loans outpacing deposits (102.9% loan-to-deposit ratio) (www.sec.gov), the bank has turned to FHLB advances and other borrowings to bridge the gap. Over $1.5 billion of FHLB advances are on the books (www.sec.gov), much of it short-term (www.sec.gov). While PFS has ample access to wholesale funds, this dependence can be a risk if credit markets tighten or funding costs spike. Notably, the bank issued $225 million of subordinated debt at a high 9% coupon in 2024 (www.sec.gov), which boosts interest expense. If market interest rates remain stubbornly high (or rise further), PFS could face margin pressure when replacing maturing FHLB lines and could be locked into expensive sub-debt until it can be refinanced. The bank mitigated some risk by using the Fed’s BTFP during the 2023 liquidity scare (locking in lower-cost funds against its securities) and has since repaid that (www.sec.gov). Additionally, management reports $7 billion in liquidity availability for contingencies (www.kbra.com). Still, investors should be alert to the refinancing risk: roughly $1.3 billion of advances come due within a year (www.sec.gov). If deposit growth lags or if wholesale funding becomes less accessible, PFS might need to curb loan growth or pay up for funds, which would squeeze earnings.

Regulatory and Capital Constraints: With ~$25 billion in assets, Provident is large enough to attract greater regulatory scrutiny. In fact, regulators conditioned the Lakeland acquisition on PFS raising capital and restraining payouts – including a $200 million Tier 2 capital raise and a requirement to pre-notify regulators before any dividend increases or share buybacks for two years post-merger (www.bankingdive.com). This means through mid-2026, PFS has limited flexibility to return additional capital to shareholders beyond its regular dividend. Furthermore, in the wake of the 2023 regional bank failures, regulators have signaled stricter rules (on liquidity, capital, and loss-absorbing debt) could be applied more broadly to mid-sized banks. If new regulations force higher capital buffers or risk management costs, PFS’s returns could be moderated. The Fed has already required PFS to maintain a Tier 1 leverage ratio of 8.5% through 2027 (www.bankingdive.com) (versus the typical 5% well-capitalized threshold), effectively keeping more equity on the balance sheet. PFS is meeting this with room to spare currently (weissratings.com), but such constraints can cap ROE or restrict aggressive growth. In short, regulatory compliance and capital requirements are a non-negligible risk – they ensure safety but could dampen shareholder upside if tightened further.

Macroeconomic & Interest-Rate Risk: Like all banks, PFS’s fortunes are tied to the broader economy. A recession or spike in unemployment in its markets (New Jersey/New York) would likely increase loan delinquencies and slow loan demand. Thus far, credit quality is strong and the economy has been resilient, but that can change. Additionally, while PFS has managed interest rate cycles well, rapid shifts pose a risk. Falling rates could pressure asset yields if loans reprice down or prepay, though PFS’s neutral interest-rate positioning should help (www.kbra.com). Conversely, persistently high rates could eventually force PFS to raise deposit rates more or accept deposit outflows, eroding its net interest margin. The bank has signaled optimism that NIM will hold up and even expand modestly as older loans reset higher (www.kbra.com) – a scenario that assumes rate cuts and funding cost relief later in 2024/2025. If instead the Fed keeps rates “higher for longer” due to inflation, banks like PFS might face a longer squeeze on deposits. PFS’s moderate deposit beta so far is encouraging, but competition for deposits in the region (from both big banks and online banks) remains a factor to watch. Any unexpected earnings miss or uptick in credit losses could quickly pressure the stock after its recent strength.

Overall, PFS’s risk profile is balanced: it has very strong asset quality metrics and risk management track record (no major credit hiccups in over a decade) (www.kbra.com), but its high CRE exposure and reliance on some costly borrowed funds are areas to keep an eye on. The bank’s capital and liquidity buffers provide a cushion, and management’s conservative stance (e.g. not chasing volatile deposits, keeping high reserves) is reassuring (www.sec.gov). In the near term, no glaring red flags like outsized unrealized securities losses or outsized tech/startup deposits (issues that plagued some peers) are evident at PFS – its securities portfolio is largely encumbered for FHLB borrowing but that is a known trade-off (www.kbra.com) (www.kbra.com). The main watch items will be credit performance in the CRE book and funding costs as the interest-rate environment evolves.

Outlook and Open Questions

Looking ahead, several open questions remain for PFS and its investors:

Can PFS reignite dividend growth or share buybacks? The quarterly dividend has been flat at $0.24 for five years. Once the two-year post-merger regulatory restriction on capital returns lapses (mid-2026) (www.bankingdive.com), will management consider a dividend increase or repurchasing shares? With a solid payout ratio and improved earnings, a modest dividend hike or buybacks could be on the table – but regulators and capital needs will influence this decision.

How will the large CRE loan portfolio perform as loans mature? A key test comes as hundreds of millions in commercial mortgages come due in the next 1–2 years. Will borrowers be able to refinance smoothly at higher rates? Thus far credit trends are benign, but investors will watch for any uptick in restructuring or non-accrual loans. The 65% of CRE borrowers that are “refractory” (having used advanced therapies, per Kroll’s note) underlines that many are seasoned investors – but rising debt service requirements could still bite. Asset quality guidance in coming quarters will be crucial to gauge whether PFS’s underwriting truly immunizes it from the broader CRE slowdown.

Can PFS boost its fee income mix? Management has emphasized growing non-interest revenue, particularly through wealth management and insurance services (www.kbra.com). These businesses not only diversify revenue but deepen customer relationships. The question is whether PFS can significantly move the needle – currently only ~14% of revenue is fee-based (www.kbra.com), below peers. Success in this area (e.g. expanding their advisory client base or insurance brokerage footprint) could improve the bank’s resilience and valuation multiple. Progress on fee-income initiatives will be something to track in upcoming earnings reports.

What is PFS’s growth strategy from here? Having digested a major merger, will Provident pursue further acquisitions or focus on organic growth? The bank is now the 7th-largest in NJ with ~4.1% deposit share (www.bankingdive.com) – there may be opportunities to acquire smaller community banks in adjoining regions, or to use its larger balance sheet to win business organically (for instance, taking market share in commercial lending or municipal banking). Management’s posture on M&A versus internal growth is an open question. Any hints of another deal or a geographic expansion plan could impact the stock’s outlook. Conversely, PFS itself could become an attractive takeover candidate for a larger bank seeking a strong NJ presence, though there are no concrete signals of this – it remains a speculative possibility given PFS’s size and clean balance sheet.

In conclusion, Provident Financial Services (PFS) has emerged from its merger larger and financially stronger, with improving profits and a well-covered dividend that appeals to shareholders. The optimistic market mood – fueled by wins in unrelated sectors like biotech – has helped PFS’s stock soar to new highs, rewarding patient investors (stockanalysis.com). Going forward, execution will be key: investors will be watching how management steers the bank through a changing rate landscape and whether it can maintain its “boring” (in the best way) credit performance. If PFS continues to deliver steady growth, manage its risks, and perhaps begin returning more capital to shareholders, there may be further upside. However, given the stock’s re-rating and the risks outlined, a prudent stance is warranted. Hope is high, but so are expectations – much like AbbVie’s hopeful trial results, PFS will need to prove it can sustain its success in the quarters ahead. (www.kbra.com) (www.kbra.com)

For informational purposes only; not investment advice.